A different approach to drug development.
We brought meaningful innovation to the pharmaceutical industry in 2008 with Quotient Sciences Translational Pharmaceutics® – a unique drug delivery platform proven to shorten development times by more than 12 months.
Integrated capabilities for drug product development and clinical testing.
Translational Pharmaceutics® accelerates molecules through development by integrating traditionally siloed services.
Drug product development and manufacturing and clinical testing activities are traditionally siloed in drug development. Multiple providers are often selected to handle these activities, creating handovers between providers that add time and cost to already complex drug development processes.
The Quotient Sciences Translational Pharmaceutics® platform allows us to optimize your drug development needs, each step of the way.
Understanding the dependencies between drug formulation design and clinical outcomes enables us to enhance development efficiency and help you achieve your goals at each development stage:
- Bridging your small molecule or synthetic peptide drug from candidate development to first in human (FIH) studies
- Accelerating out of FIH studies to proof of concept (POC)
- Manufacturing your drug product at commercial scale
By integrating activities, we help you reach key milestones as quickly and efficiently as possible.
Benefits of Translational Pharmaceutics®
See how Quotient Sciences enable a faster, integrated approach to drug development.
Streamlines & simplifies
vendor management & supply chain
Better decisions
based on emerging human clinical data
Provides flexibility
to adjust formulation composition within a study
Timeline acceleration
by 12 months or more
Cost savings
in R&D spend
What our customers say about Translational Pharmaceutics®
Ready to see how Translational Pharmaceutics® can be applied to your next drug program? Contact us today.